Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia ; volume:8 ; number:1 ; day:3 ; month:4 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (3.4.2018), 1-9, 12.2018
- Creator
-
Stockard, Bradley
- Contributor
-
Garrett, Timothy
Guingab-Cagmat, Joy
Meshinchi, Soheil
Lamba, Jatinder
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-23863-9
- URN
-
urn:nbn:de:101:1-2018053121312647679644
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stockard, Bradley
- Garrett, Timothy
- Guingab-Cagmat, Joy
- Meshinchi, Soheil
- Lamba, Jatinder
- SpringerLink (Online service)
Other Objects (12)
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Effekte von FLT3-ITD Inhibitoren auf Chemotherapie resistente AML Zelllinien
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Untersuchungen zur Inhibition von Autophagie in FLT3-ITD-mutierten AML-Zellen
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Effekte von FLT3-ITD Inhibitoren auf Chemotherapie resistente AML Zelllinien
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Untersuchungen zur Inhibition von Autophagie in FLT3-ITD-mutierten AML-Zellen
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Effekte von FLT3-ITD Inhibitoren auf Chemotherapie resistente AML Zelllinien
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Untersuchungen zur Inhibition von Autophagie in FLT3-ITD-mutierten AML-Zellen
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo